| Product Name | MF | CAS | Details |
|---|
| Voriconazole EP Impurity D | C16H14F3N5O | 137234-63-0 | Details |
| (1，3-dichloropropyl)benzene | C9H10Cl2 | 14155-36-3 | Details |
| Vonoprazan Impurity 2 | C17H15ClFN3O2S | 928325-68-2 | Details |
| Voriconazole Impurity 2 | C16H13ClF3N5O | 137234-75-4 | Details |
| Valsartan Impurity 2 | C25H30N2O3 | 137863-90-2 | Details |
| Voriconazole Impurity 1 | C16H14F3N5O | 182230-43-9 | Details |
| Valsartan Impurity 3 | C19H21N5O | 914465-68-2 | Details |
| Vonoprazan Impurity 39 | C8H5Br2FO | 1224739-02-9 | Details |
| Vortioxetine Impurity 21 | C20H24N2OS | 1801352-86-2 | Details |
| Vildagliptin Impurity 3 | C10H14N2O2 | 6708-06-1 | Details |
| Vortioxetine Impurity 20 | C18H22N2O2S | 1639263-80-1 | Details |
| Vonoprazan Impurity 35 | C17H17N3O2S | 881732-90-7 | Details |
| Voriconazole EP Impurity B | C16H15F2N5O | 182369-73-9 | Details |
| Vonoprazan Impurity 37 | C12H13FN2 | 1610043-62-3 | Details |
| 1-(1-ethylpyrrolidin-2-yl)-N-methylmethanamine | C8H18N2 | 60923-27-5 | Details |
| Vildagliptin Impurity 4 | C10H14N2O2 | 19943-27-2 | Details |
| 1，4-dinitrosopiperazine | C4H8N4O2 | 140-79-4 | Details |
| Vildagliptin Impurity 1 | C10H16N2O2 | 243145-00-8 | Details |
| Aripiprazole Impurity 1 | C22H27Cl5N4 | 519138-48-8 | Details |
| Chlorphenamine Impurity 1 | C16H19ClN2O | 120244-82-8 | Details |
| 4-Hydroxy Lidocaine | C14H22N2O2 | 39942-41-1 | Details |
| (S，S)-Formoterol | C19H24N2O4 | 67346-48-9 | Details |
| Gadobutrol Impurity 6 | C12H24N4O4 | 112193-75-6 | Details |
| Levocetirizine Impurity 20 | C24H31ClN2O5 | 1243652-36-9 | Details |
| Levocetirizine Impurity 24 | C22H27ClN2O3 | 83881-46-3 | Details |
| Medetomidine Impurity 7 | C13H17ClN2 | 145108-58-3 | Details |
| Moxifloxacin impurity 13 | C15H16F3NO4 | 121577-35-3 | Details |
| Moxifloxacin impurity 19 | C17H16F2N2O3 | 929962-29-8 | Details |
| Medetomidine Impurity 1 | C15H20N2 | 2250243-24-2 | Details |
| Medetomidine Impurity 26 | C10H12 | 27831-13-6 | Details |
| Medetomidine Impurity 17 | C11H16O | 2514763-84-7 | Details |
| Norfloxacin EP Impurity B | C14H16FN3O3 | 75001-77-3 | Details |
| Cefditoren Pivoxi Impurity 2 | C25H28N6O7S3 | 148774-47-4 | Details |
| Desonide USP Impurity G | C24H31BrO6 | 39672-77-0 | Details |
| 2-Methyl-3-(trifluoromethyl)pivalanilide | C13H16F3NO | 150783-50-9 | Details |
| Erythromycin A 9-Oxime | C37H68N2O13 | 13127-18-9 | Details |
| Cefditoren Pivoxi Impurity 7 | C30H36N6O8S3 | 878002-84-7 | Details |
| Cefditoren Pivoxi Impurity 3 | C25H28N6O7S3 | 138514-32-6 | Details |
| N-(2-chloro-5-(trifluoromethyl)phenyl)pivalamide | C12H13ClF3NO | 13691-96-8 | Details |
| Fusidic Acid EP Impurity G（ Sodium Fusidate EP Impurity G） | C31H46O6 | 4680-37-9 | Details |
| Telmisartan Ethyl Ester | C35H34N4O2 | 528560-94-3 | Details |
| Valsartan Impurity 4 | C19H21N5O2 | 676129-92-3 | Details |
| Trifluridine Impurity 2 | C10H11F3N2O5 | 7057-42-3 | Details |
| Doxazosin Impurity 2 | C10H12N4O2 | 60547-96-8 | Details |
| Terazosin EP Impurity H | C18H23N5O4 | 105356-90-9 | Details |
| Tartrazine Impurity 3 | C12H11N3O6S2 | 17596-06-4 | Details |
| Tofacitinib Impurity 8 | C14H20N6O | 1640971-60-3 | Details |
| Tofacitinib Impurity 2 | C22H28N6O8 | 2174011-55-1 | Details |
| Tofacitinib Impurity 20 | C16H22N6O2 | 1675248-19-7 | Details |
| Tofacitinib Impurity 18 | C21H27N7O3 | 2459302-85-1 | Details |
| Thioctic Acid Impurity 1 | C10H19ClO3 | 1070-65-1 | Details |
| Terazosin EP Impurity I | C20H27N5O4 | 1177261-85-6 | Details |
| Terazosin EP Impurity D | C15H19N5O3 | 102714-74-9 | Details |
| Tartrazine Impurity 1 | C12H12N3NaO6S2 | 56120-28-6 | Details |
| Trimetazidine EP Impurity A | C14H22N2O3 | 52146-35-7 | Details |
| Thioctic Acid Impurity 4 | C8H14O4S2 | 17370-41-1 | Details |
| Terazosin EP Impurity F | C19H27N5O4 | 109678-71-9 | Details |
| Terazosin EP Impurity J | C19H27N5O4 | 152551-75-2 | Details |
| Tenofovir Impurity 8 | C10H15O6PS | 161760-03-8 | Details |
| Valsartan Impurity 1 | C20H23N5O2 | 1111177-24-2 | Details |
| Telmisartan EP Impurity C | C37H38N4O2 | 144702-26-1 | Details |
| Tenofovir Impurity 12 | C8H11N5O | 1244022-52-3 | Details |
| Tenofovir Impurity 11 | C13H22N5O4P | 180587-75-1 | Details |
| Tenofovir Impurity 26 | C8H10BrN5 | 1884329-63-8 | Details |
| Ticagrelor Impurity 4 | C10H19NO4 | 2165799-36-8 | Details |
| Tedizolid Impurity 4 | C34H29F2N12O8P | 1256966-02-5 | Details |
| Tranexamic Acid EP Impurity C HCl | C8H14ClNO2 | 1803601-44-6 | Details |
| Tranexamic Acid EP Impurity A | C16H27NO4 | 93940-19-3 | Details |
| Tedizolid Impurity 1 | C16H14FN6O6P | 1239662-47-5 | Details |
| Torasemide Impurity 1 | C13H13N3O2S | 947327-54-0 | Details |
| Torasemide EP Impurity D | C17H22N4O3S | 160972-33-8 | Details |
| Torasemide EP Impurity E | C15H17N3O4S | 72810-57-2 | Details |
| Tenofovir Impurity 24 | C11H18N5O4P | 1796545-19-1 | Details |
| Telmisartan EP Impurity G | C33H29N5 | 144702-27-2 | Details |
| Tedizolid Impurity 16 | C7H6BrN5 | 380380-63-2 | Details |
| Tranexamic Acid EP Impurity E | C16H28N2O3 | 82755-59-7 | Details |
| Tedizolid Impurity 5 | C16H18FN6O5P | 2095200-69-2 | Details |
| Ticagrelor Impurity 1 | C20H22F2N6O5 | 1644461-81-3 | Details |
| Debenzoic Acid Bromo Telmisartan | C26H25BrN4 | 1004548-55-3 | Details |
| Telmisartan EP Impurity B | C33H30N4O2 | 1026353-20-7 | Details |
| Tenofovir Impurity 5 | C15H25N6O5P | 851456-00-3 | Details |
| Tipiracil Impurity 1 | C5H6N2O3 | 22126-44-9 | Details |
| Tenofovir Impurity 9 | C8H11O6PS | 161760-09-4 | Details |
| N-Formyl Trimetazidine HCl | C15H23ClN2O4 | 879646-17-0 | Details |
| Tofacitinib Impurity 5 | C14H21N5 | 2227197-38-6 | Details |
| Terazosin Impurity 1 | C10H12ClN3O3 | 134749-43-2 | Details |
| Tartrazine Impurity 2 | C4H6O8 | 76-30-2 | Details |
| Terbutaline Impurity 5 | C18H23N | 30923-82-1 | Details |
| Terazosin EP Impurity G | C18H23N5O4 | 105356-89-6 | Details |
| USP Trifluridine Related Compound A | C10H12N2O7 | 14599-46-3 | Details |
| Valproic Acid EP Impurity I | C8H15N | 13310-75-3 | Details |
| Valproic Acid EP Impurity G | C11H23NO | 52061-73-1 | Details |
| Tofacitinib Impurity 11 | C16H22N6O | 1640972-35-5 | Details |
| Tofacitinib Impurity 14 | C16H20N6O | 344418-92-4 | Details |
| Tofacitinib Impurity 7 | C20H29N5O3 | 2227199-31-5 | Details |
| Tedizolid Impurity 17 | C10H10BrNO3 | 1252686-47-7 | Details |
| Telmisartan EP Impurity J | C33H29ClN4O2 | 885045-90-9 | Details |
| Telmisartan EP Impurity F | C33H31N5O | 915124-86-6 | Details |
| Tedizolid Impurity 2 | C17H17FN6O9P2 | 1239662-48-6 | Details |
| Tedizolid Impurity 10 | C13H15BrFNO5 | 2044712-34-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 | ||||